펩트론

087010KOSDAQ기초 의약물질 제조업

49.6 / 100

Reference Date: 2026-06-10

Financial Score14.0 / 40

News Sentiment17.6 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, Operating Profit is on a declining trend. Slightly down 4.8% over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

Peptron develops smart pharmaceuticals using peptide engineering and sustained-release technology, operating a GMP large-scale production facility for clinical trials and commercial products. The pharmaceutical industry is characterized by high R&D costs and long-term profitability, with the sustained-release drug sector maintaining an oligopolistic structure due to high manufacturing barriers even after patent expirations.

Number of Employees

160people

Average Salary

58.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 27.714.0Point

PBR

—Industry Average 1.743.5Point

ROE

-9.41Industry Average -6.033.5Point

1.6x industry avg (good)

Debt Ratio

21.10Industry Average 6.620.0Point

3.2x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲36.5% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼16.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -22.9% (improving, 3yr)

Detailed News Sentiment

14 totalPositive 3Neutral 2Negative 9Average Sentiment Score 70.4

Positive
하루만에 반등…코스피 8%대 상승 마감
코스피의 급격한 상승으로 펩트론을 포함한 관련 주식들이 하루 만에 반등하며 긍정적 영향을 받음.
Negative
코스피, 8% 떨어진 7400선 마감…코스닥도 9%↓
코스피와 코스닥 모두 큰 폭 하락하며 서킷브레이커와 매도 사이드카 발동으로 마감, 반도체주 하락이 주요 원인.
Negative
젠슨 황 방한에도…8100선 위협받은 코스피, 약세 마감
코스피 약세로 펩트론 주가에 부정적 영향 예상.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 245,000Won52-week high 386,00052-week low 185,000

1-month return2.0Point

1m -4.85% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-05-29
Neutral분기보고서 (2026.03)2026-05-15